Safety Concerns Prevented EU Approval For GSK’s Jesduvroq In Non-Dialysis CKD Patients

 
• By Eliza Slawther

The European Medicines Agency recommended against the approval of GSK’s Jesduvroq in patients with CKD-related anemia who are not on dialysis because of concerns around its safety profile in these patients.

Drug Safety
• Source: Shutterstock

More from Europe

More from Geography